Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
NOD2 and Crohn’s Disease: Loss or Gain of Function? — Lars Eckmann (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Shared by
Michael Karin
University of California, San Diego
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Article
2005
en
Related publications
Article
2005
<i>Nod2</i> Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Shin Maeda
,
Li‐Chung Hsu
,
Hongjun Liu
,
Laurie A. Bankston
,
Mitsutoshi Iimura
,
Martin F. Kagnoff
,
Lars Eckmann
,
Michael Karin
Article
2004
Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis
Authors
LE
Lars Eckmann
Michael Karin
University of California, San Diego
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Michael Economou
,
Thomas A Trikalinos
,
Konstantinos T. Loizou
,
Epameinondas V. Tsianos
,
John P A Ioannidis
Article
2003
A Crohn's disease‐associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo‐plantar pustular psoriasis or guttate psoriasis
Celia N. Young
,
Michael H. Allen
,
Andrew Cuthbert
,
M. Ameen
,
Colin Veal
,
J. Leman
,
A. David Burden
,
Brian Kirby
,
Christopher Em Griffiths
,
Richard C. Trembath
,
Christopher G. Mathew
,
Juliet N. Barker
Article
2006
Gain‐ and loss‐of‐function mutations in <i>Zat10</i> enhance the tolerance of plants to abiotic stress
Ron Mittler
,
YongSig Kim
,
Luhua Song
,
Jesse Coutu
,
Alicia Coutu
,
Sultan Ciftci-Yilmaz
,
Hojoung Lee
,
Becky Stevenson
,
Jian Kang Zhu
Article
2024
S1092 Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study
Feyzullah Aksan
,
Lokman Hekim Tanrıverdi
,
Layla Barrera
,
Thomas Ullman
Discussion(0)
No comments yet. Be the first to comment.